Zynex, Inc. Logo

Zynex, Inc.

ZYXI

(1.8)
Stock Price

7,80 USD

6.43% ROA

14.15% ROE

40.73x PER

Market Cap.

245.686.950,00 USD

189.51% DER

0% Yield

3.12% NPM

Zynex, Inc. Stock Analysis

Zynex, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Zynex, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (25.38%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (117), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (5.19x) suggests it's overvalued, potentially making it an expensive investment.

6 DER

The stock is burdened with a heavy load of debt (130%), making it financially unstable and potentially risky for investors.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Zynex, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Zynex, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Zynex, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Zynex, Inc. Revenue
Year Revenue Growth
1997 89.486
1998 12.414 -620.85%
1999 0 0%
2000 160.883 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 1.256.676 100%
2005 2.258.808 44.37%
2006 2.556.809 11.66%
2007 8.048.252 68.23%
2008 11.763.558 31.58%
2009 18.681.242 37.03%
2010 24.085.000 22.44%
2011 34.148.000 29.47%
2012 39.666.000 13.91%
2013 21.684.000 -82.93%
2014 11.117.000 -95.05%
2015 11.641.000 4.5%
2016 13.313.000 12.56%
2017 23.432.000 43.18%
2018 31.917.000 26.58%
2019 45.472.000 29.81%
2020 80.122.000 43.25%
2021 130.301.000 38.51%
2022 158.167.000 17.62%
2023 199.660.000 20.78%
2023 184.322.000 -8.32%
2024 199.532.000 7.62%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Zynex, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 874.000 100%
2013 754.000 -15.92%
2014 394.000 -91.37%
2015 256.000 -53.91%
2016 256.000 0%
2017 100.000 -156%
2018 200.000 50%
2019 600.000 66.67%
2020 800.000 25%
2021 2.600.000 69.23%
2022 7.100.000 63.38%
2023 0 0%
2023 9.200.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Zynex, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 1.161.955 100%
2001 37.354 -3010.66%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 4.702.000 100%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 8.336.000 100%
2019 11.576.000 27.99%
2020 18.323.000 36.82%
2021 26.324.000 30.39%
2022 36.108.000 27.1%
2023 50.924.000 29.09%
2023 48.517.000 -4.96%
2024 57.840.000 16.12%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Zynex, Inc. EBITDA
Year EBITDA Growth
1997 -73.114
1998 -10.624 -588.2%
1999 -25.280 57.97%
2000 -1.584.602 98.4%
2001 -37.354 -4142.12%
2002 -22.720 -64.41%
2003 -35.521 36.04%
2004 -886.288 95.99%
2005 -67.428 -1214.42%
2006 75.852 188.89%
2007 3.528.752 97.85%
2008 718.695 -390.99%
2009 4.495.354 84.01%
2010 2.340.000 -92.11%
2011 3.908.000 40.12%
2012 3.683.000 -6.11%
2013 -6.684.000 155.1%
2014 -5.084.000 -31.47%
2015 -2.064.000 -146.32%
2016 871.000 336.97%
2017 8.944.000 90.26%
2018 10.370.000 13.75%
2019 11.066.000 6.29%
2020 11.744.000 5.77%
2021 22.366.000 47.49%
2022 22.938.000 2.49%
2023 26.464.000 13.32%
2023 15.000.000 -76.43%
2024 13.536.000 -10.82%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Zynex, Inc. Gross Profit
Year Gross Profit Growth
1997 44.901
1998 6.207 -623.39%
1999 0 0%
2000 -71.486 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 1.019.032 100%
2005 1.949.181 47.72%
2006 2.253.090 13.49%
2007 7.319.206 69.22%
2008 9.523.924 23.15%
2009 14.887.894 36.03%
2010 18.883.000 21.16%
2011 26.777.000 29.48%
2012 30.896.000 13.33%
2013 13.544.000 -128.12%
2014 3.505.000 -286.42%
2015 6.704.000 47.72%
2016 9.796.000 31.56%
2017 18.613.000 47.37%
2018 25.879.000 28.08%
2019 36.658.000 29.4%
2020 62.705.000 41.54%
2021 102.980.000 39.11%
2022 126.162.000 18.37%
2023 161.448.000 21.86%
2023 145.956.000 -10.61%
2024 159.648.000 8.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Zynex, Inc. Net Profit
Year Net Profit Growth
1997 -91.255
1998 -16.840 -441.89%
1999 -25.402 33.71%
2000 -1.628.516 98.44%
2001 -128.772 -1164.65%
2002 -94.752 -35.9%
2003 -145.618 34.93%
2004 -975.878 85.08%
2005 107.956 1003.96%
2006 -320.370 133.7%
2007 2.131.350 115.03%
2008 110.952 -1820.97%
2009 2.382.312 95.34%
2010 350.000 -580.66%
2011 1.564.000 77.62%
2012 1.553.000 -0.71%
2013 -7.301.000 121.27%
2014 -6.199.000 -17.78%
2015 -2.911.000 -112.95%
2016 69.000 4318.84%
2017 7.365.000 99.06%
2018 9.552.000 22.9%
2019 9.492.000 -0.63%
2020 9.074.000 -4.61%
2021 17.103.000 46.94%
2022 17.048.000 -0.32%
2023 14.376.000 -18.59%
2023 9.732.000 -47.72%
2024 4.868.000 -99.92%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Zynex, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 -22
1998 0 0%
1999 -18 100%
2000 -683 97.36%
2001 -82 -741.98%
2002 -1 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Zynex, Inc. Free Cashflow
Year Free Cashflow Growth
1997 36.284
1998 0 0%
1999 0 0%
2000 -1.065.469 100%
2001 -31.841 -3246.22%
2002 -226.278 85.93%
2003 -9.453 -2293.72%
2004 -1.106.736 99.15%
2005 -233.142 -374.7%
2006 -635.046 63.29%
2007 -11.447 -5447.71%
2008 -2.163.055 99.47%
2009 2.692.837 180.33%
2010 -1.337.000 301.41%
2011 -1.629.000 17.93%
2012 -2.218.000 26.56%
2013 -1.026.000 -116.18%
2014 689.000 248.91%
2015 341.000 -102.05%
2016 1.474.000 76.87%
2017 8.173.000 81.97%
2018 8.326.000 1.84%
2019 6.143.000 -35.54%
2020 -167.000 3778.44%
2021 6.340.000 102.63%
2022 13.328.000 52.43%
2023 8.657.000 -53.96%
2023 16.740.000 48.29%
2024 997.000 -1579.04%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Zynex, Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 36.284
1998 0 0%
1999 0 0%
2000 -945.179 100%
2001 -31.841 -2868.43%
2002 -226.278 85.93%
2003 -9.453 -2293.72%
2004 -1.060.987 99.11%
2005 -217.058 -388.8%
2006 -483.460 55.1%
2007 746.863 164.73%
2008 -715.160 204.43%
2009 3.648.024 119.6%
2010 -665.000 648.58%
2011 -362.000 -83.7%
2012 -879.000 58.82%
2013 -382.000 -130.1%
2014 961.000 139.75%
2015 341.000 -181.82%
2016 1.700.000 79.94%
2017 8.260.000 79.42%
2018 9.408.000 12.2%
2019 6.303.000 -49.26%
2020 818.000 -670.54%
2021 6.949.000 88.23%
2022 13.746.000 49.45%
2023 8.893.000 -54.57%
2023 17.946.000 50.45%
2024 1.134.000 -1482.54%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Zynex, Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 0
1998 0 0%
1999 0 0%
2000 120.290 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 45.749 100%
2005 16.084 -184.44%
2006 151.586 89.39%
2007 758.310 80.01%
2008 1.447.895 47.63%
2009 955.187 -51.58%
2010 672.000 -42.14%
2011 1.267.000 46.96%
2012 1.339.000 5.38%
2013 644.000 -107.92%
2014 272.000 -136.76%
2015 0 0%
2016 226.000 100%
2017 87.000 -159.77%
2018 1.082.000 91.96%
2019 160.000 -576.25%
2020 985.000 83.76%
2021 609.000 -61.74%
2022 418.000 -45.69%
2023 236.000 -77.12%
2023 1.206.000 80.43%
2024 137.000 -780.29%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Zynex, Inc. Equity
Year Equity Growth
1998 122
1999 0 0%
2000 -594.944 100%
2001 -948.542 37.28%
2002 -961.219 1.32%
2003 -891.106 -7.87%
2004 202.893 539.2%
2005 440.769 53.97%
2006 1.287.454 65.76%
2007 3.617.541 64.41%
2008 4.774.078 24.23%
2009 7.486.296 36.23%
2010 8.182.000 8.5%
2011 10.140.000 19.31%
2012 12.055.000 15.89%
2013 4.848.000 -148.66%
2014 -1.267.000 482.64%
2015 -4.071.000 68.88%
2016 -3.802.000 -7.08%
2017 4.902.000 177.56%
2018 9.298.000 47.28%
2019 19.653.000 52.69%
2020 56.855.000 65.43%
2021 73.925.000 23.09%
2022 66.358.000 -11.4%
2023 46.129.000 -43.85%
2023 58.582.000 21.26%
2024 32.816.000 -78.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Zynex, Inc. Assets
Year Assets Growth
1998 122
1999 0 0%
2000 146.264 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 789.601 100%
2005 1.344.897 41.29%
2006 2.768.344 51.42%
2007 7.175.170 61.42%
2008 10.783.996 33.46%
2009 11.929.959 9.61%
2010 15.701.000 24.02%
2011 21.785.000 27.93%
2012 25.909.000 15.92%
2013 17.221.000 -50.45%
2014 7.114.000 -142.07%
2015 3.696.000 -92.48%
2016 4.091.000 9.66%
2017 8.929.000 54.18%
2018 16.184.000 44.83%
2019 28.277.000 42.77%
2020 72.175.000 60.82%
2021 133.274.000 45.84%
2022 116.466.000 -14.43%
2023 141.074.000 17.44%
2023 151.429.000 6.84%
2024 121.915.000 -24.21%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Zynex, Inc. Liabilities
Year Liabilities Growth
1998 0
1999 0 0%
2000 741.208 100%
2001 948.542 21.86%
2002 961.219 1.32%
2003 891.106 -7.87%
2004 586.708 -51.88%
2005 904.128 35.11%
2006 1.480.890 38.95%
2007 3.557.629 58.37%
2008 6.009.918 40.8%
2009 4.443.663 -35.25%
2010 7.519.000 40.9%
2011 11.645.000 35.43%
2012 13.854.000 15.94%
2013 12.373.000 -11.97%
2014 8.381.000 -47.63%
2015 7.767.000 -7.91%
2016 7.893.000 1.6%
2017 4.027.000 -96%
2018 6.886.000 41.52%
2019 8.624.000 20.15%
2020 15.320.000 43.71%
2021 59.349.000 74.19%
2022 50.108.000 -18.44%
2023 94.945.000 47.22%
2023 92.847.000 -2.26%
2024 89.099.000 -4.21%

Zynex, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
6.1
Net Income per Share
0.19
Price to Earning Ratio
40.73x
Price To Sales Ratio
1.27x
POCF Ratio
13.39
PFCF Ratio
14.24
Price to Book Ratio
7.49
EV to Sales
1.5
EV Over EBITDA
19.22
EV to Operating CashFlow
15.78
EV to FreeCashFlow
16.79
Earnings Yield
0.02
FreeCashFlow Yield
0.07
Market Cap
0,25 Bil.
Enterprise Value
0,29 Bil.
Graham Number
2.1
Graham NetNet
-1.03

Income Statement Metrics

Net Income per Share
0.19
Income Quality
3.04
ROE
0.14
Return On Assets
0.05
Return On Capital Employed
0.1
Net Income per EBT
0.71
EBT Per Ebit
0.81
Ebit per Revenue
0.05
Effective Tax Rate
0.29

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0.05
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.8
Operating Profit Margin
0.05
Pretax Profit Margin
0.04
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.58
Free CashFlow per Share
0.54
Capex to Operating CashFlow
0.06
Capex to Revenue
0.01
Capex to Depreciation
0.24
Return on Invested Capital
0.08
Return on Tangible Assets
0.06
Days Sales Outstanding
44.48
Days Payables Outstanding
73.59
Days of Inventory on Hand
143.69
Receivables Turnover
8.21
Payables Turnover
4.96
Inventory Turnover
2.54
Capex per Share
0.03

Balance Sheet

Cash per Share
0,97
Book Value per Share
1,03
Tangible Book Value per Share
0.15
Shareholders Equity per Share
1.03
Interest Debt per Share
2.02
Debt to Equity
1.9
Debt to Assets
0.51
Net Debt to EBITDA
2.92
Current Ratio
4.06
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
99207000
Working Capital
0,06 Bil.
Intangibles to Total Assets
0.23
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
15433000
Debt to Market Cap
0.25

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Zynex, Inc. Dividends
Year Dividends Growth
2014 0
2018 0 0%
2022 0 0%

Zynex, Inc. Profile

About Zynex, Inc.

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

CEO
Mr. Thomas Sandgaard
Employee
1.100
Address
9655 Maroon Circle
Englewood, 80112

Zynex, Inc. Executives & BODs

Zynex, Inc. Executives & BODs
# Name Age
1 Mr. Daniel J. Moorhead
Chief Financial Officer
70
2 Ms. Anna Lucsok
Chief Operating Officer
70
3 Mr. Neil Friery
President & Chief Operating Officer of Zynex Monitoring Solutions, Inc.
70
4 Mr. Thomas Sandgaard
Founder, President, Chief Executive Officer & Chairman
70
5 Mr. Donald Gregg
President of Zynex Monitoring Solutions
70
6 Mr. Steve Fox
Vice President Of Sales
70

Zynex, Inc. Competitors